CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes

Tarih

Yazarlar

Schnell, Oliver

Barnard\\-Kelly, Katharine

Battelino, Tadej

Ceriello, Antonio

Larsson, Helena Elding

Fernandez\\-Fernandez, Beatriz

Frias, Juan \\-Pablo

Gavin III, James R.

Giorgino, Francesco

Yayınevi

VERLAG KIRCHHEIM

Anahtar kelimeler

Cardiovascular disease Chronic kidney disease CGM Diabetes Finerenone, GLP\\-1 RA Guidelines Heart failure MASLD NAFLD Obesity SGLT2 inhibitor, Teplizumab

URI

https://openaccess.acibadem.edu.tr/handle/11443/6414

Koleksiyonlar

Tam öğe sayfası